JACQUELYN WILLIAMS: Open Payments
NPI 1396942074 · LAS CRUCES, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$680 in 35 payments from 13 companies in 2025. Trend: 2023 $1,062 · 2024 $797 · 2025 $680
Food & beverage: $680
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 10 | $140 |
| Neurocrine BioSciences, Inc. | 6 | $135 |
| Lundbeck LLC | 3 | $72 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 2 | $30 |
| Alpha Cognition USA, Inc. | 1 | $29 |
| ABBVIE INC. | 1 | $25 |
Products named: ARISTADA, INGREZZA, REXULTI, CAPLYTA, TRINTELLIX, COBENFY, AUSTEDO XR, Zunveyl.
Industry payments across NM — which companies pay providers there.
